Navigation Links
VGI Announces the Launch of DISMISS Instruments for the VerteLoc™ Minimally Invasive Spine Stabilization System
Date:3/3/2009

VGI introduces a revolutionary surgical instrument system that is smaller in diameter than a pencil. The DISMISS® instrument system is designed specifically for the implantation of the VerteLoc™ Minimally Invasive Spine Stabilization System and will be unveiled at the Congress of Neurological Surgeons meeting in Phoenix, Arizona starting on March 12, 2009.

Winston-Salem, NC (PRWEB) March 3, 2009 -- VG Innovations, Inc. (VGI), announces the launch of a new surgical instrumentation system, named DISMISS®.

"DISMISS® stands for Directional Instrument System for Minimally Invasive Spine Surgery," stated VGI's President and CEO, Dan Grayson. "We have received very positive feedback from our surgeon users, regarding the biomechanical advantages of the VerteLoc™ Minimally Invasive Spine Stabilization system, so the next logical step was to further refine the system's current instrumentation. We have now taken minimally invasive spinal facet fusion to a whole new level with the DISMISS® instruments."

"The DISMISS® instruments, used specifically for the implantation of the VerteLoc™ implants, are smaller in diameter than a pencil," noted Executive Vice President and Chief Technical Officer Dr. Tov Vestgaarden. "In addition, we have not only reduced the size, but also the number of instruments required for surgical implantation. This is just the beginning of a whole new era in surgical instrumentation from VGI."

"New sets of the DISMISS® instruments will be distributed during the second and third quarters of 2009 to select VGI distributors throughout the United States," Grayson added. "These new instruments will allow our distributors to introduce the VerteLoc™ system
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related biology technology :

1. AcroMetrix Announces the Release of OptiQuant-S Hepatitis C Virus (HCV) Panel
2. Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma
3. CUREXO Technology Corporation Announces New Headquarters
4. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
5. Bionovo Announces Publication of Positive Phase 2 Trial Results for Menerba(TM)
6. Epistem Announces Research and Development Collaboration With a Major Pharmaceutical Company
7. Miami Beach Real Estate Attorney Announces Services to Assist Chinese and other International Real Estate Investors Purchase Discount Florida Homes
8. Sigma-Aldrich (NASDAQ:SIAL) Announces it Has Filed Its December 31, 2008 Form 10-K
9. Finesse Announces TruTorr(TM) Single-Use Pressure Sensor
10. Vasogen Announces 2008 Year-End Results
11. NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus (RSV) Vaccine Candidate Directed Against the Fusion (F) Protein
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
VGI Announces the Launch of DISMISS Instruments for the VerteLoc™ Minimally Invasive Spine Stabilization System 
(Date:8/31/2015)... ... 31, 2015 , ... There’s a new treatment option for excessive menstrual bleeding ... new FDA approved system in the last 14 years, and the only endometrial ablation ... bleeding) rate of 66%, the high Patient Satisfaction rate of 98%, and the fastest ...
(Date:8/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/zsgg5n/global_and_usa ... & USA BioSimilar Market Analysis to 2021" report ... Biosimilar market will be initiated in September as Sandoz ... the global market react? Will biosimilars explode into the ... the US economy up to $250 billion within the ...
(Date:8/28/2015)... Pittsburgh, PA (PRWEB) , ... August 28, 2015 ... ... Program Chairman, Chuck Gardner, has organized and will present a session on chemical ... September 2. This conference and exposition is Asia’s largest analytical and scientific instruments ...
(Date:8/28/2015)... ... August 28, 2015 , ... Since the initial launch of FireflySci Inc. (FFS) in early 2015, ... customer service. Images such as the Fonz in a lab coat and Large Marge ... the humdrum spectroscopy field. , FireflySci is proud to be the only cuvette ...
Breaking Biology Technology:U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3Global & USA BioSimilar Market Analysis Report 2015-2021 2Global & USA BioSimilar Market Analysis Report 2015-2021 3U.S. Symposium on Imaging Organized by Pittcon’s Program Chairman Chuck Gardner 2U.S. Symposium on Imaging Organized by Pittcon’s Program Chairman Chuck Gardner 3Cuvette Manufacturer FireflySci Launches Back to School Deals with Complimentary Shipping On All Orders 2
... Incorporated (Nasdaq: SPEX ), an innovator in ... and regulatory consulting services to food, supplement, biotechnology and ... the 2009 BIO International Conference in Atlanta, Georgia on ... Control Drug" booth will showcase their ongoing global phase ...
... Biomarkers and Non-Invasive Imaging to Demonstrate Mechanism of Action ... May 14 VIA Pharmaceuticals, Inc. (Nasdaq: ... of compounds for the treatment of cardiovascular and metabolic ... a Phase 2 clinical trial of its lead drug, ...
... manufacturing facility opens with substantially increased capacity, ... Biosystems Inc. (TSX:MBX) announced today robust double digit growth ... for the second quarter ended March 31, 2009. , ... of Microbix said "Our 43% growth in the first ...
Cached Biology Technology:Spherix to Exhibit at the BIO 2009 International Convention 2VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients 2VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients 3VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients 4VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients 5Microbix Sales Grow Over 30% In The Second Quarter; Up 43% In The First Half '09 2Microbix Sales Grow Over 30% In The Second Quarter; Up 43% In The First Half '09 3Microbix Sales Grow Over 30% In The Second Quarter; Up 43% In The First Half '09 4
(Date:8/25/2015)... and BELLEVUE, Wash. , Aug. ... advanced robotic systems, announced today it will unveil its ... vehicle (UGV), at the National Tactical Officers Association Conference ... The Guardian S is the first-ever commercially available ... years of research and in-field trials and is protected ...
(Date:8/20/2015)... CT ., Aug. 20, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... announces it has joined The Smart Card Alliance and ... Smart Card Alliance and the Smart Card Alliance Latin ... visibility to industry peers and thought leaders promoting adoption ...
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2
... United States and Great Britain will speak at The ... and his theory of evolution, which continues to excite ... Darwins death. , The free one-day symposium will be ... 5:00 p.m. at The Field Museums James Simpson Theater. ...
... Darwin Foundation (CDF) botanists have published a list of ... Island, the third largest town in Galapagos. 261 species ... Despite 95% of the archipelago falling under the ... areas are having large impacts on the native flora ...
... in an intermittent on/off switch for a gene involved in ... found in a study of human brain tissue. The ... high rates during normal development of the prefrontal cortex, the ... and decision-making but that this normal increase may not ...
Cached Biology News:Darwin Symposium at Field Museum offers broad overview of his science and its impact 2Darwin Symposium at Field Museum offers broad overview of his science and its impact 3How schizophrenia develops: Major clues discovered 2
...
... White walled plates enhance luminescent signals ... fluorescence,• Not treated (or medium binding) ... and binds biomolecules through passive interactions,• ... of large molecules, such as antibodies, ...
... H-IPMIK-OH Lyophilized solid. Supplied as ... PACKAGED UNDER INERT GAS. A cell-permeable mutated ... No. 196810) that serves as a negative ... μM). Purity: ≥97% by HPLC. ...
...
Biology Products: